Abstract

Simple SummaryGlioblastoma (GBM) is the most aggressive primary malignant brain tumor in adults. Despite standard treatment, including surgery, chemotherapy, and radiotherapy, it is associated with poor survival. Immunotherapy is a promising alternative for patients with GBM. Natural killer (NK) cells are possible promising targets in GBM treatment because of their potent cytotoxic effect. We previously reported that highly activated and ex vivo-expanded NK cells, or genuine induced NK cells (GiNK), exert a greatly cytotoxic effect on GBM cells. In this study, we investigated the potential of NK cell-based immunotherapy for GBM, which we evaluated using an ex vivo three-dimensional GBM cell-derived spheroid model. Our results indicated that the NK cells had an anti-tumor effect on the spheroid models. Our findings could lead to the development of future NK cell-based immunotherapies for GBM.Glioblastoma (GBM) is the most common and aggressive primary brain tumor, with a dismal prognosis. Natural killer (NK) cells are large granular lymphocytes with natural cytotoxicity against tumor cells, and they should be established for the novel treatment of patients with GBM. We previously reported highly activated, and ex vivo-expanded NK cells derived from human peripheral blood, designated genuine induced NK cells (GiNK), which were induced by specific culture conditions and which exerted a cytotoxic effect on GBM cells via apoptosis. Here, we comprehensively summarize the molecular characteristics, especially focusing on the expression of stem cell markers, extracellular matrix markers, chemokines, chemokine receptors, and NK receptor ligands of spheroids derived from GBM cell lines as compared with that of two-dimensional (2D) adherent GBM cells via microarray. The spheroid had upregulated gene expression of stem cell markers, extracellular matrix markers, chemokines, chemokine receptors, and NK cell inhibitory receptor ligands compared with the 2D adherent GBM cells. Preclinical evaluation of the NK cells was performed via an ex vivo 3D spheroid model derived from GBM cell lines. In the model, the NK cells accumulated and infiltrated around the spheroids and induced GBM cell death. Flow cytometry-based apoptosis detection clearly showed that the NK cells induced GBM cell death via apoptosis. Our findings could provide pivotal information for NK cell-based immunotherapy for patients with GBM.

Highlights

  • Glioblastoma (GBM) is the most common and lethal primary brain tumor, classified as grade IV by the World Health Organization (WHO) [1]

  • We previously reported genuine induced Natural killer (NK) cells (GiNK), highly purified and expanded human NK cells derived from peripheral blood mononuclear cells (PBMCs) using a chemically defined and feeder-free method such as cancer cells and that exhibited high

  • SOX2, STAT3, and CD133 were significantly expressed in GBM tissue compared with normal brain tissue in The Cancer Genome Atlas (TCGA) database

Read more

Summary

Introduction

Glioblastoma (GBM) is the most common and lethal primary brain tumor, classified as grade IV by the World Health Organization (WHO) [1]. New strategies are needed for treating patients with GBM, and immunotherapy can be a promising adjuvant treatment. Several such clinical trials have recently been reported [3,4,5,6], but these therapies did not improve the OS in patients with GBM. Natural killer (NK) cells were discovered more than 40 years ago and are considered to play an important role in controlling virus infections and tumor progression to mediate cytotoxicity and produce cytokines [7,8,9]. NK cell development and maturation are dependent on type I interferon (IFN) and the cytokines interleukin (IL)-12, IL-15, and IL-18 [10,11,12,13] and are trained through signals transduced by the activation and inhibitory receptors [14,15,16,17]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call